When one opens up a copy of the Economist magazine, one does not expect to see a full-page ad from Shell touting the superb innovation chops of Evansville Mater Dei High School. The front section four-color ad (which also appeared in Sept. 6 Time magazine) profiled the Evansville school for building...Read More
The numbers are all up, but nobody believes them. U.S. economic news looks better than it has for years, but a Wall Street Journal/NBC News poll (in August 2014) found “widespread economic anxiety” at “record levels.” Why? The devastating Great Recession scarred millions, leading to stubborn...Read More
For many hospitals, early fall is strategic planning and budgeting time. What can a hospital do now to make 2015 a standout year? As the healthcare regulatory and compensation environments swirl ever more complex, can smaller and rural area hospitals and clinics effectively compete with larger urban...Read More
Cookie-cutter or stand-out? In the days before selfies and raw cut video, people were memorable for a reason. While I’ve had the privilege of meeting and working with a number of celebrities in my career, few top the class exhibited by the late Lauren Bacall. What might that mean for you and your personal...Read More
Fresh from his trip to the Farnborough Air Show in England, Indiana Governor Mike Pence delivered a thoughtful “message of hope” for Indiana July 22, touting the emerging possibility of Hoosierland becoming the literal “envy of America.” Indiana has much to celebrate, but also has much to consider....Read More
“Any given day at The MEK Group may involve helping an international medical manufacturing services company expand and capture U.S. market share, developing a premium brand and ad campaign for a communications enterprise, organizing industry leaders and academics to advance a technology region, or...Read More
“We did not develop this medicine [Nexavar] for Indians, we developed it for western patients who can afford it.” These inflammatory words, uttered by Bayer AG Chairman Marijn Dekkers at a Financial Times global pharmaceutical forum last month, have flared into an international firestorm,...Read More
If you’re on a calendar fiscal year, right now you’re probably plugging in semi-final numbers for the C-execs to bless in your 2014 operating plan. You probably went through your business goals, threw up some modest growth figures (to possibly have them sent back for rationale that shows faster and...Read More
